Insmed Incorporated (INSM)
INSM price $94.04 -1.63 -1.70%
- Ticker
- INSM
- Price
- $94.04
- Change
- -1.63 -1.70%
- Market cap
- $20.54B
- P/E
- -23.28
- Forward P/E
- 117.66
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 68
Insmed Incorporated operates as a biopharmaceutical enterprise focused on creating and introducing medical solutions for individuals facing severe and uncommon health conditions. The company's marketed treatment, ARIKAYCE, is administered to adult patients suffering from Mycobacterium avium complex (MAC) lung disease, serving as a component of a broader antibacterial drug regimen. In its development pipeline, Insmed…